시장보고서
상품코드
1878941

dPCR 및 qPCR 제품 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 - 제품별, 용도별, 최종사용자별, 지역별, 경쟁별(2020-2030년)

dPCR and qPCR Products Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Application, By End User, By Region and Competition, 2020-2030F

발행일: | 리서치사: TechSci Research | 페이지 정보: 영문 180 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 디지털 중합효소 연쇄 반응(dPCR) 및 정량 중합효소 연쇄 반응(qPCR) 제품 시장은 2024년에 82억 4,000만 달러로 평가되었으며, 2030년까지 CAGR 7.39%로 성장하여 126억 4,000만 달러에 달할 것으로 예측됩니다.

디지털 중합효소 연쇄 반응(dPCR) 및 정량적 중합효소 연쇄 반응(qPCR) 제품은 핵산의 정밀한 검출 및 정량화를 목적으로 하는 분자진단 도구입니다. qPCR이 상대적 또는 절대적 정량을 위한 실시간 증폭을 측정하는 반면, dPCR은 절대적 정량을 위해 샘플을 분할하여 희소 표적에 대한 민감도를 높입니다. 시장 성장은 감염성 및 유전성 질환의 전 세계 유병률 증가와 분석 효율을 향상시키는 지속적인 기술 발전에 힘입어 성장세를 보이고 있습니다. 또한, 현장 진단 및 맞춤형 의료에 대한 채택의 증가도 성장의 모멘텀을 촉진하고 있습니다.

시장 개요
예측 기간 2026-2030년
시장 규모 : 2024년 82억 4,000만 달러
시장 규모 : 2030년 126억 4,000만 달러
CAGR : 2025-2030년 7.39%
가장 빠르게 성장하는 부문 시약·소모품
최대 시장 북미

주요 시장 촉진요인

주요 시장 과제

주요 시장 동향

자주 묻는 질문

  • 디지털 중합효소 연쇄 반응(dPCR) 및 정량 중합효소 연쇄 반응(qPCR) 제품 시장의 규모는 어떻게 되나요?
  • 디지털 중합효소 연쇄 반응(dPCR)과 정량 중합효소 연쇄 반응(qPCR)의 주요 차이점은 무엇인가요?
  • 디지털 중합효소 연쇄 반응(dPCR) 및 정량 중합효소 연쇄 반응(qPCR) 제품 시장의 주요 성장 요인은 무엇인가요?
  • 디지털 중합효소 연쇄 반응(dPCR) 및 정량 중합효소 연쇄 반응(qPCR) 제품 시장에서 가장 빠르게 성장하는 부문은 무엇인가요?
  • 디지털 중합효소 연쇄 반응(dPCR) 및 정량 중합효소 연쇄 반응(qPCR) 제품 시장의 최대 시장은 어디인가요?

목차

제1장 개요

제2장 조사 방법

제3장 주요 요약

제4장 고객의 소리

제5장 세계의 dPCR 및 qPCR 제품 시장 전망

  • 시장 규모 및 예측
    • 금액별
  • 시장 점유율과 예측
    • 제품별(시약·소모품, 기기, 소프트웨어)
    • 용도별(임상 용도, 법의학 용도)
    • 최종사용자별(병원·진단 센터, 연구소·학술기관, 임상 연구기관, 기타)
    • 지역별
    • 기업별(2024)
  • 시장 맵

제6장 북미의 dPCR 및 qPCR 제품 시장 전망

  • 시장 규모 및 예측
  • 시장 점유율과 예측
  • 북미 : 국가별 분석
    • 미국
    • 캐나다
    • 멕시코

제7장 유럽의 dPCR 및 qPCR 제품 시장 전망

  • 시장 규모 및 예측
  • 시장 점유율과 예측
  • 유럽 : 국가별 분석
    • 독일
    • 영국
    • 이탈리아
    • 프랑스
    • 스페인

제8장 아시아태평양의 dPCR 및 qPCR 제품 시장 전망

  • 시장 규모 및 예측
  • 시장 점유율과 예측
  • 아시아태평양 : 국가별 분석
    • 중국
    • 인도
    • 일본
    • 한국
    • 호주

제9장 남미의 dPCR 및 qPCR 제품 시장 전망

  • 시장 규모 및 예측
  • 시장 점유율과 예측
  • 남미 : 국가별 분석
    • 브라질
    • 아르헨티나
    • 콜롬비아

제10장 중동 및 아프리카의 dPCR 및 qPCR 제품 시장 전망

  • 시장 규모 및 예측
  • 시장 점유율과 예측
  • 중동 및 아프리카 : 국가별 분석
    • 남아프리카공화국
    • 사우디아라비아
    • 아랍에미리트

제11장 시장 역학

  • 성장 촉진요인
  • 과제

제12장 시장 동향과 발전

  • 최근 동향
  • 인수합병
  • 제품 출시

제13장 세계의 dPCR 및 qPCR 제품 시장 : SWOT 분석

제14장 Porter's Five Forces 분석

  • 업계내 경쟁
  • 신규 참여의 가능성
  • 공급업체의 능력
  • 고객의 능력
  • 대체품의 위협

제15장 경쟁 구도

  • Abbott Laboratories, Inc.
  • Agilent Technologies, Inc.
  • Analytik Jena AG
  • Becton Dickinson and Company
  • Bio Molecular Systems Pty Ltd.
  • Biomeme Inc.
  • Biomerieux S.A.
  • Bioneer Corporation
  • Bio-Rad Laboratories, Inc.
  • Cole-Parmer Instrument Company llc

제16장 전략적 제안

제17장 조사 회사 소개 및 면책사항

KSM 25.12.15

The Global dPCR and qPCR Products Market , valued at USD 8.24 Billion in 2024, is projected to experience a CAGR of 7.39% to reach USD 12.64 Billion by 2030. Digital Polymerase Chain Reaction (dPCR) and quantitative Polymerase Chain Reaction (qPCR) products are molecular diagnostic tools for precise nucleic acid detection and quantification. qPCR measures real-time amplification for relative or absolute quantification, while dPCR segments samples for absolute quantification, enhancing sensitivity for scarce targets. Market growth is driven by the rising global prevalence of infectious diseases and genetic disorders, alongside continuous technological advancements improving assay efficiency. Increased adoption in point-of-care diagnostics and personalized medicine also provides momentum.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 8.24 Billion
Market Size 2030USD 12.64 Billion
CAGR 2025-20307.39%
Fastest Growing SegmentReagents & Consumables
Largest MarketNorth America

Key Market Drivers

The increasing global prevalence of infectious diseases and genetic disorders constitutes a primary driver for the dPCR and qPCR products market. These advanced molecular diagnostic tools offer the sensitivity and specificity required for early detection and accurate quantification of pathogens and genetic mutations, which is crucial for effective disease management and public health initiatives. For instance, according to the WHO Global Tuberculosis Report 2024, published on November 1, 2024, approximately 8.2 million people were newly diagnosed with tuberculosis in 2023, a notable increase from 7.5 million in 2022, highlighting the persistent and growing burden of infectious diseases that necessitate precise diagnostic solutions. Similarly, the expanding understanding of genetic predispositions and heritable conditions fuels the demand for high-resolution genetic analysis enabled by dPCR and qPCR.

Key Market Challenges

High capital expenditure associated with digital Polymerase Chain Reaction (dPCR) instrumentation and specialized reagents presents a significant impediment to the growth of the Global dPCR and qPCR Products Market. The substantial upfront investment required for advanced dPCR systems, coupled with the ongoing costs of specific reagents, creates a financial barrier for potential adopters. This directly constrains market expansion by limiting the accessibility of these technologies to a wider range of laboratories, especially smaller research facilities, clinical diagnostic centers with restricted budgets, and institutions in emerging economies.

Key Market Trends

The integration of AI and cloud-based data analytics is transforming PCR workflows, enhancing data processing, interpretation, and accessibility. AI algorithms provide more precise analysis of complex assay results, improving diagnostic accuracy and accelerating turnaround times. Cloud platforms offer scalable solutions for data storage and collaborative research, vital for managing increasing genomic data volumes. QIAGEN, for instance, announced in April 2025 its upcoming QIAsymphony Connect system will integrate digital connectivity and be compatible with QIAsphere, its cloud-based platform for remote monitoring. This market evolution towards sophisticated computational infrastructure is further evidenced by the Association for Molecular Pathology in May 2025, releasing three interrelated Body of Knowledge papers defining essential bioinformatics competencies for clinical diagnostic laboratories.

Key Market Players

  • Abbott Laboratories, Inc.
  • Agilent Technologies, Inc.
  • Analytik Jena AG
  • Becton Dickinson and Company
  • Bio Molecular Systems Pty Ltd
  • Biomeme Inc.
  • Biomerieux S.A.
  • Bioneer Corporation
  • Bio-Rad Laboratories, Inc.
  • Cole-Parmer Instrument Company LLC

Report Scope:

In this report, the Global dPCR and qPCR Products Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

dPCR and qPCR Products Market , By Product:

dPCR and qPCR Products Market , By Application:

  • Reagents & Consumables
  • Instruments
  • Software

dPCR and qPCR Products Market , By End User:

  • Clinical Applications
  • Forensic Applications

dPCR and qPCR Products Market , By Region:

  • Hospitals & Diagnostic Centers
  • Research Laboratories & Academic Institutes
  • Clinical Research Organizations
  • Others

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global dPCR and qPCR Products Market .

Available Customizations:

Global dPCR and qPCR Products Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validations
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global dPCR and qPCR Products Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Reagents & Consumables, Instruments, Software)
    • 5.2.2. By Application (Clinical Applications, Forensic Applications)
    • 5.2.3. By End User (Hospitals & Diagnostic Centres, Research Laboratories & Academic Institutes, Clinical Research Organizations, Others)
    • 5.2.4. By Region
    • 5.2.5. By Company (2024)
  • 5.3. Market Map

6. North America dPCR and qPCR Products Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Application
    • 6.2.3. By End User
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States dPCR and qPCR Products Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Application
        • 6.3.1.2.3. By End User
    • 6.3.2. Canada dPCR and qPCR Products Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Application
        • 6.3.2.2.3. By End User
    • 6.3.3. Mexico dPCR and qPCR Products Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Application
        • 6.3.3.2.3. By End User

7. Europe dPCR and qPCR Products Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Application
    • 7.2.3. By End User
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany dPCR and qPCR Products Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By End User
    • 7.3.2. United Kingdom dPCR and qPCR Products Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By End User
    • 7.3.3. Italy dPCR and qPCR Products Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecasty
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By End User
    • 7.3.4. France dPCR and qPCR Products Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Application
        • 7.3.4.2.3. By End User
    • 7.3.5. Spain dPCR and qPCR Products Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Application
        • 7.3.5.2.3. By End User

8. Asia-Pacific dPCR and qPCR Products Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Application
    • 8.2.3. By End User
    • 8.2.4. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China dPCR and qPCR Products Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By End User
    • 8.3.2. India dPCR and qPCR Products Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By End User
    • 8.3.3. Japan dPCR and qPCR Products Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By End User
    • 8.3.4. South Korea dPCR and qPCR Products Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By End User
    • 8.3.5. Australia dPCR and qPCR Products Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By End User

9. South America dPCR and qPCR Products Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Application
    • 9.2.3. By End User
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil dPCR and qPCR Products Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By End User
    • 9.3.2. Argentina dPCR and qPCR Products Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By End User
    • 9.3.3. Colombia dPCR and qPCR Products Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By End User

10. Middle East and Africa dPCR and qPCR Products Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Application
    • 10.2.3. By End User
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa dPCR and qPCR Products Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By End User
    • 10.3.2. Saudi Arabia dPCR and qPCR Products Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By End User
    • 10.3.3. UAE dPCR and qPCR Products Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Global dPCR and qPCR Products Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Abbott Laboratories, Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Company Snapshot
    • 15.1.3. Products & Services
    • 15.1.4. Financials (As Reported)
    • 15.1.5. Recent Developments
    • 15.1.6. Key Personnel Details
    • 15.1.7. SWOT Analysis
  • 15.2. Agilent Technologies, Inc.
  • 15.3. Analytik Jena AG
  • 15.4. Becton Dickinson and Company
  • 15.5. Bio Molecular Systems Pty Ltd.
  • 15.6. Biomeme Inc.
  • 15.7. Biomerieux S.A.
  • 15.8. Bioneer Corporation
  • 15.9. Bio-Rad Laboratories, Inc.
  • 15.10. Cole-Parmer Instrument Company llc

16. Strategic Recommendations

17. About Us & Disclaimer

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제